307 related articles for article (PubMed ID: 25950799)
1. Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin.
Herman A; Gruden K; Blejec A; Podpečan V; Motaln H; Rožman P; Hren M; Zupančič K; Veber M; Verbovšek U; Lah Turnšek T; Porčnik A; Koršič M; Knežević M; Jeras M
PLoS One; 2015; 10(5):e0125791. PubMed ID: 25950799
[TBL] [Abstract][Full Text] [Related]
2. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients.
Géczi D; Nagy B; Szilágyi M; Penyige A; Klekner Á; Jenei A; Virga J; Birkó Z
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064637
[TBL] [Abstract][Full Text] [Related]
4. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study.
Rahmati Y; Alivand M; Mollanoori H
Comput Biol Chem; 2021 Jun; 92():107458. PubMed ID: 33761401
[TBL] [Abstract][Full Text] [Related]
5. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
[TBL] [Abstract][Full Text] [Related]
6. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.
Qiu S; Lin S; Hu D; Feng Y; Tan Y; Peng Y
J Transl Med; 2013 Jan; 11():10. PubMed ID: 23302469
[TBL] [Abstract][Full Text] [Related]
7. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
Wang Q; Li P; Li A; Jiang W; Wang H; Wang J; Xie K
J Exp Clin Cancer Res; 2012 Nov; 31(1):97. PubMed ID: 23174013
[TBL] [Abstract][Full Text] [Related]
8. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
9. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform.
Swellam M; Ezz El Arab L; Al-Posttany AS; B Said S
J Neurooncol; 2019 Sep; 144(3):545-551. PubMed ID: 31422498
[TBL] [Abstract][Full Text] [Related]
11. miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
Dong L; Li Y; Han C; Wang X; She L; Zhang H
Int J Oncol; 2014 Aug; 45(2):746-56. PubMed ID: 24858071
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
Ahir BK; Ozer H; Engelhard HH; Lakka SS
Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
Kefayat A; Amouheidari A; Ghahremani F; Alirezaei Z
Cancer Med; 2021 Aug; 10(15):5154-5162. PubMed ID: 34250760
[TBL] [Abstract][Full Text] [Related]
14. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW
Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437
[TBL] [Abstract][Full Text] [Related]
15. Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells.
Ondracek J; Fadrus P; Sana J; Besse A; Loja T; Vecera M; Radova L; Smrcka M; Slampa P; Slaby O
Anticancer Res; 2017 Mar; 37(3):1099-1104. PubMed ID: 28314270
[TBL] [Abstract][Full Text] [Related]
16. Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival.
Sana J; Busek P; Fadrus P; Besse A; Radova L; Vecera M; Reguli S; Stollinova Sromova L; Hilser M; Lipina R; Lakomy R; Kren L; Smrcka M; Sedo A; Slaby O
Sci Rep; 2018 Feb; 8(1):2836. PubMed ID: 29434344
[TBL] [Abstract][Full Text] [Related]
17. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
18. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
Chen J; Yang L; Wang X
Cancer Biomark; 2017 Dec; 20(4):521-526. PubMed ID: 28946553
[TBL] [Abstract][Full Text] [Related]
19. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease.
Candido S; Lupo G; Pennisi M; Basile MS; Anfuso CD; Petralia MC; Gattuso G; Vivarelli S; Spandidos DA; Libra M; Falzone L
Oncol Rep; 2019 Sep; 42(3):911-922. PubMed ID: 31322245
[TBL] [Abstract][Full Text] [Related]
20. Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme.
Li WB; Chen HY; Zhang W; Yan W; Shi R; Li SW; Jiang T
Chin Med J (Engl); 2013; 126(15):2881-5. PubMed ID: 23924460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]